Further, we analysed NGAL levels in serum of patients with pancreatic cancer to investigate whether serum NGAL could be used to distinguish patients with pancreatic cancer from those with pancreatitis or disease-free pancreas. The gene discussed is LCN2; the disease is familial pancreatic carcinoma.